Dual CEA/CD44 targeting to colorectal cancer cells using nanobody-conjugated hyaluronic acid-modified mesoporous silica nanoparticles with pH- and redox-sensitivity
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.